QbTest Utility for Optimising Treatment in ADHD (QUOTA)

Not Applicable

Completed

• Conditions: Specialty: Mental health, Primary sub-specialty: Learning disorders - ADHD; UKCRC code/ Disease: Mental Health/ Behavioural and emotional disorders with onset usually occurring in childhood and adolescence; Mental and Behavioural Disorders

• Registration Number: ISRCTN69461593
• Lead Sponsor: ottinghamshire Healthcare NHS Foundation Trust

Brief Summary

2018 Protocol article in https://www.ncbi.nlm.nih.gov/pubmed/29453304 protocol 2019 Protocol article in https://www.ncbi.nlm.nih.gov/pubmed/31215440 developing the protocol (added 21/06/2019) 2021 Results article in https://pubmed.ncbi.nlm.nih.gov/33726855/ (added 28/06/2022)

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2018-04-10
• Study Completion: 2019-03-31
• Last Update Posted: 5 August 2022

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

1. Age 6-17 years (may turn 18 during the study)
2. Confirmed clinical diagnosis of ADHD
3. Joint clinician/parent/young person decision to start stimulant medication for ADHD or review effectiveness of medication in CAMHS or Community Paediatric services
4. Capable of providing written consent
5. Parental consent (under 16 years)

Exclusion Criteria

1. Unable to give informed consent
2. Severe learning difficulty
3. Not started on a stimulant medication (e.g. non-stimulant medication is prescribed or the family choose not to start medication at all)
4. Non-fluent English

Study & Design

• Study Type: Interventional
• Study Design: Not specified